Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. (AMRX) — SEC Financial Statements & Analysis
Amneal Pharmaceuticals, Inc. (AMRX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Common Class A | 0 | 0 | 0 | -313 | 313 | 0 | 0 | 1 | 309 | 0 | 0 | 1 | |||||
Common Class B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Related Party | 851 | 895 | 78 | 53 | 754 | 776 | -22 | 101 | 669 | 614 | 16 | 675 | |||||
Nonrelated Party | 851 | 895 | 78 | 53 | 754 | 776 | -22 | 101 | 669 | 614 | 16 | 675 | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 198 | 282 | 201 | 72 | 59 | 111 | 74 | 44 | 47 | 92 | 87 | 109 | |||||
Restricted Cash And Cash Equivalents At Carrying V… | 4 | 29 | 35 | 10 | 7 | 8 | 4 | 6 | 5 | 8 | 9 | 5 | |||||
Inventory Net | 642 | 606 | 615 | 609 | 601 | 612 | 596 | 576 | 571 | 581 | 576 | 551 | |||||
Prepaid Expense And Other Assets Current | 103 | 98 | 102 | 85 | 89 | 81 | 82 | 82 | 87 | 83 | 91 | 82 | |||||
Assets Current | 1,798 | 1,911 | 1,838 | 1,585 | 1,510 | 1,588 | 1,513 | 1,485 | 1,380 | 1,378 | 1,456 | 1,422 | |||||
Property Plant And Equipment Net | 445 | 443 | 435 | 440 | 427 | 425 | 431 | 425 | 440 | 448 | 452 | 459 | |||||
Goodwill | 594 | 595 | 596 | 597 | 597 | 597 | 598 | 599 | 599 | 599 | 599 | 599 | |||||
Intangible Assets Net Excluding Goodwill | 535 | 563 | 588 | 650 | 689 | 732 | 780 | 820 | 859 | 890 | 983 | 1,015 | |||||
Operating Lease Right Of Use Asset | - | 54 | - | - | - | 42 | - | - | - | 43 | - | - | |||||
Other Assets Noncurrent | 55 | 58 | 39 | 45 | 45 | 60 | 36 | 77 | 74 | 56 | 89 | 93 | |||||
Assets | 3,540 | 3,678 | 3,600 | 3,423 | 3,365 | 3,501 | 3,461 | 3,510 | 3,456 | 3,473 | 3,687 | 3,701 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Litigation Reserve Current | 11 | 43 | 41 | 42 | 44 | 32 | 30 | 31 | 30 | 77 | 77 | 77 | |||||
Lines Of Credit Current | - | 0 | 0 | 290 | 290 | 100 | 140 | 179 | 179 | 179 | 76 | 120 | |||||
Long Term Debt Current | 6 | 7 | 7 | 31 | 32 | 224 | 225 | 225 | 34 | 34 | 31 | 30 | |||||
Liabilities Current | 728 | 882 | 862 | 1,107 | 1,076 | 1,130 | 1,095 | 1,114 | 834 | 847 | 761 | 777 | |||||
Long Term Debt Noncurrent | 2,566 | 2,565 | 2,567 | 2,146 | 2,154 | 2,162 | 2,170 | 2,178 | 2,378 | 2,386 | 2,542 | 2,549 | |||||
Other Notes Payable | - | - | - | - | - | - | 0 | 0 | 42 | 41 | 41 | 41 | |||||
Litigation Reserve Noncurrent | 70 | 72 | 74 | 74 | 73 | 85 | 85 | 85 | 85 | 0 | - | - | |||||
Liabilities Noncurrent | 2,772 | 2,791 | 2,780 | 2,362 | 2,349 | 2,416 | 2,399 | 2,400 | 2,639 | 2,565 | 2,735 | 2,741 | |||||
Temporary Equity Carrying Amount Including Portion… | 86 | 77 | 68 | 66 | 73 | 65 | 60 | 53 | 47 | 41 | 37 | 32 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 536 | 572 | 563 | 555 | 546 | 560 | 553 | 546 | 539 | 539 | 715 | 708 | |||||
Retained Earnings Accumulated Deficit | -473 | -535 | -570 | -572 | -595 | -607 | -576 | -576 | -582 | -490 | -392 | -401 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -112 | -111 | -106 | -97 | -86 | -66 | -74 | -30 | -24 | -32 | 4 | 8 | |||||
Stockholders Equity | -46 | -71 | -109 | -112 | -132 | -109 | -93 | -57 | -64 | 20 | 331 | 151 | |||||
Minority Interest | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -177 | -167 | |||||
Liabilities And Stockholders Equity | 3,540 | 3,678 | 3,600 | 3,423 | 3,365 | 3,501 | 3,461 | 3,510 | 3,456 | 3,473 | 3,687 | 3,701 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.01% | 25.58% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 1.39% | 12.60% | 11.63% | 16.44% | 18.76% | 28.50% | 7.38% | 11.06% | 14.84% | -14.34% | 0.72% | -13.61% |
| 2024 | 1.37% | -3.64% | 12.90% | 13.20% | 7.06% | 9.80% | -8.65% | -15.46% | -10.70% | -0.12% | -15.11% | -12.34% |
| 2023 | 37.10% | 66.67% | 69.89% | -5.80% | -5.80% | -15.85% | 12.29% | 46.27% | 32.29% | 13.54% | 25.42% | 23.93% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.47 | 2.17 | 2.13 | 1.43 | 1.40 | 1.41 | 1.38 | 1.33 | 1.65 | 1.63 | 1.91 | 1.83 | |||||
| Quick Ratio | 1.45 | 1.37 | 1.30 | 0.80 | 0.76 | 0.79 | 0.76 | 0.74 | 0.87 | 0.84 | 1.04 | 1.02 | |||||
| Working Capital | 1.07B | 1.03B | 976.37M | 477.56M | 434.63M | 458.04M | 418.09M | 371.13M | 545.66M | 531.27M | 695.47M | 644.44M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -76.14 | -51.48 | -33.27 | -30.95 | -26.01 | -32.38 | -37.40 | -61.12 | -54.50 | 170.47 | 10.57 | 23.33 | |||||
| Interest Coverage TTM | 1.83 | 1.63 | 1.45 | 1.51 | 1.44 | 0.96 | 0.73 | 0.72 | 0.70 | 0.97 | 1.14 | 1.03 | |||||
| Debt Ratio | 0.99 | 1.00 | 1.01 | 1.01 | 1.02 | 1.01 | 1.01 | 1.00 | 1.00 | 0.98 | 0.95 | 0.95 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.88 | 0.84 | 0.83 | 0.82 | 0.83 | 0.80 | 0.75 | 0.72 | 0.70 | 0.66 | 0.63 | 0.60 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 0.55 | 0.39 | 0.19 | 0.22 | 0.13 | -0.24 | -0.44 | -0.44 | -0.43 | -0.14 | -0.36 | -0.41 | |||||
| Free Cash Flow Per Share TTM | 0.76 | 0.86 | 0.84 | 0.90 | 0.81 | 0.79 | 0.86 | 0.68 | 0.52 | 0.86 | 0.46 | 0.48 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 38.66% | 36.88% | 36.76% | 37.67% | 36.69% | 36.52% | 35.34% | 35.04% | 35.28% | 34.28% | 35.46% | 34.94% | |||||
| Operating Profit Margin TTM | 14.30% | 13.05% | 12.19% | 13.19% | 12.73% | 8.92% | 7.00% | 6.72% | 6.38% | 8.54% | 9.48% | 8.43% | |||||
| Net Profit Margin TTM | 5.95% | 4.24% | 2.13% | 2.52% | 1.50% | -2.64% | -5.12% | -5.36% | -5.35% | -2.04% | -4.80% | -5.49% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 7.62% | 8.05% | 9.50% | 9.81% | 13.42% | 16.73% | 12.32% | 12.37% | 9.82% | 8.20% | 11.54% | 8.92% | |||||
| Net Income Growth (1Y) | 327.78% | -273.17% | -145.61% | -151.67% | -131.77% | 51.63% | 19.91% | 9.85% | -48.60% | -80.88% | -21.65% | -15.16% | |||||
| EPS Growth (1Y) | 321.05% | -270.75% | -144.96% | -150.91% | -131.38% | 72.87% | 19.44% | 9.27% | -49.11% | -83.61% | -23.08% | -16.67% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 21.66 | 30.86 | 50.23 | 35.25 | 61.50 | -33.12 | -18.77 | -14.09 | -13.96 | -43.89 | -11.37 | -7.51 | |||||
| P/B | -85.45 | -55.36 | -28.73 | -22.64 | -19.80 | -22.35 | -27.57 | -34.14 | -29.22 | 106.86 | 3.93 | 6.32 | |||||
| P/S TTM | 1.29 | 1.31 | 1.07 | 0.89 | 0.92 | 0.88 | 0.96 | 0.76 | 0.75 | 0.89 | 0.55 | 0.41 | |||||
| Market Cap | 3.93B | 3.95B | 3.14B | 2.54B | 2.61B | 2.45B | 2.58B | 1.96B | 1.86B | 2.14B | 1.30B | 953.18M | |||||
| Enterprise Value | 6.30B | 6.55B | 5.52B | 4.93B | 5.01B | 4.81B | 5.03B | 4.50B | 4.41B | 4.64B | 3.85B | 3.54B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 240.77M | 269.93M | 264.31M | 282.99M | 251.03M | 243.18M | 266.21M | 211.11M | 158.73M | 302.36M | 141.65M | 146.39M | |||||
| Net Debt | 2.37B | 2.60B | 2.37B | 2.40B | 2.41B | 2.37B | 2.46B | 2.54B | 2.54B | 2.50B | 2.55B | 2.59B | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data